1. Cooperative action of non-digestible oligosaccharides improves lipid metabolism of high-fat diet-induced mice.
- Author
-
Li Y, Kong H, Li C, Gu Z, Ban X, and Li Z
- Subjects
- Animals, Mice, Male, Insulin Resistance, Weight Gain drug effects, Oligosaccharides pharmacology, Oligosaccharides metabolism, Diet, High-Fat, Lipid Metabolism drug effects, Gastrointestinal Microbiome drug effects, Mice, Inbred C57BL, Obesity metabolism, Obesity diet therapy
- Abstract
Non-digestible oligosaccharides are known to exert health-promoting effects. However, the specific mechanisms by which they regulate host physiology remain unclear. Understanding these mechanisms will facilitate the development of non-digestible oligosaccharide compositions that can achieve synergistic effects. This study selected three representative non-digestible oligosaccharides, namely xylo-oligosaccharides (XOS), galacto-oligosaccharides (GOS), and isomalto-oligosaccharides (IMO), to investigate their effects as dietary interventions on mice fed a high-fat diet. The results demonstrated that XOS and IMO synergistically mitigated weight gain and ectopic lipid deposition. Further analysis revealed that XOS significantly altered the composition of the gut microbiota, while IMO significantly enhanced insulin sensitivity via the PI3K/Akt pathway. Moreover, the combination of XOS and IMO synergistically promoted the oxidation and breakdown of fatty acids and increased the abundance of acetate and propionate-producing bacteria, such as Lactobacillus . These findings suggest a novel strategy for obesity management based on dietary intervention with XOS and IMO.
- Published
- 2024
- Full Text
- View/download PDF